Stay updated on Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value on the webpage has been updated from 10 to 22. This change likely pertains to a specific data point or metric in medical and healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-05-23T07:49:48.000Z thumbnail image
  4. Check
    4 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 6 to 7, indicating a recent update in medical or healthcare-related publications or documentation.
    Difference
    0.3%
    Check dated 2024-05-22T07:46:09.000Z thumbnail image
  5. Check
    5 days ago
    No Change Detected
  6. Check
    14 days ago
    Change Detected
    Summary
    The value 04 22 has been updated to 05 10 on the webpage, indicating a recent change in the information related to a study record concerning the safety and efficacy of Pembrolizumab in combination with investigational agents or Pembrolizumab alone in participants with first-line advanced melanoma.
    Difference
    0.6%
    Check dated 2024-05-11T17:17:17.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Difference
    3%
    Check dated 2024-04-30T22:36:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combinations in 1L Advanced Melanoma Clinical Trial page.